Our history
From a bright idea to worldwide well integrity services
Brinker was established to commercialise the unique and patented Platelet® technology, developed from an idea in 1998 by Dr. Iain McEwan. His ‘eureka moment’ came to him after receiving a paper cut to his finger and considering how platelets in the blood stream constantly patrol our veins and initiate the sealing of cuts and wounds in the human body. The business was born to develop the Platelet® concept of introducing discrete particles to oil and gas wells and pipelines remotely, to locate and seal leaks. Since then, we have seen many milestones in the Brinker journey to market adoption in many parts of the world.
In the early years, in co-operation with the industry’s leading operators, extensive research and development was undertaken to understand how platelets could be introduced into the fluid flow and how different flow regimes impact the movement of platelets to the leak location. Material science drove the optimal Platelet® design, and polymeric and elastomeric materials are generally used for oil and gas applications, as they have no negative effect on system infrastructure and are more durable than steel.
Building upon this strong R&D foundation, numerous field trials and multiple market requests, Brinker is now focused on enabling its customers to address the industry’s well integrity challenges. Our business has the right balance of experienced and talented individuals who are pioneering the oilfield applications of Platelet® technology to solve some of the industry’s largest challenges of bringing shut-in wells back on line. We are now enabling our customers to implement field-wide integrity programmes by bringing multiple wells back on line, in many cases, in just hours.
- ...all from a small paper cut on a finger!
